Clinical Trial Update: SPP100 (Aliskiren) Regimen in Patients With Severe Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial of SPP100 (Aliskiren) regimen in patients with severe hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Aliskiren (Aliskiren)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED